Marler Clark Marler Clark

Foodborne Illnesses / Hemolytic Uremic Syndrome /

HUS References

  1. Kunzendorf U, Karch H, Werber D, Haller H. (2011). Recent outbreak of hemolytic uremic syndrome in Germany. Kid Int. 80(9):900-2.
  2. Joseph A, et al. (2020). Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review. Toxins. 12(2):67.
  3. Karmali MA. (2009). Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome. Kid Int. 75(Supp. 112):S4-S7.
  4. Tarr PI, Gordon CA, Chandler WL. (2005). Shiga-toxin-producing Escherichia coli and hemolytic uraemic syndrome. Lancet. 365(9464):1073-86.
  5. Croxen A, et al. (2013). Recent Advances in Understanding Enteric Pathogenic Escherichia Coli. Clin Microbiol Rev. 26(4):822-80.
  6. Andreoli SP, Zimmerhackl LB. Hemolytic uremic syndrome. In: Geary DF, Shaefer F, eds. Comprehensive Pediatric Nephrology 1st ed, Philadelphia, PA: Mosby, Elsevier; 2008.
  7. Kemper MJ. (2012). Outbreak of hemolytic uremic syndrome caused by E. Coli O104:H4 in Germany: a pediatric perspective. Pediatr Nephrol. 27(2):161-4.
  8. Liu Y, et al. (2011). Shiga Toxin Type 2 (Stx2), a Potential Agent of Bioterrorism, Has a Short Distribution and a Long Elimination Half-Life, and Induces Kidney and Thymus Lesions in Rats. Arch Toxicol. 85(9):1133-40.
  9. Qin J, et al. (2011). Identification of the Shiga Toxin-Producing Escherichia coli O104:H4 Strain Responsible for a Food Poisoning Outbreak in Germany by PCR. J Clin Microbiol. 49(9):3439-40.
  10. Bell BP, et al. (1997). Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics. 100(1):E12.
  11. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. (2000). The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 342(26):1930-6.
  12. Safdar N, Said A, Gangnon RE, Maki GD. (2002). Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA. 288(8):996-1001.
  13. Amerling R, Ronco C, Winchester J. (2012). Continuous Flow Peritoneal Dialysis: Update 2012. Contrib Nephrol. 178:205-15.
  14. Walsh PR, Sally J. (2019). Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome. Pediatr Nephrol. 34(9):1485-92.
  15. Menne J, et al. (2012). Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ. 345:e4565.
  16. Kielstein JT, et al. (2012). Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant. 27(10):3807-15.
  17. Sheoran AS, et al. (2005). Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun. 73(8):4607-13.
  18. Khalid M, Andreoli S. (2018). Extrarenal Manifestations of the Hemolytic Uremic Syndrome Associated With Shiga Toxin-Producing Escherichia Coli (STEC HUS). Pediatr Nephrol. 34(12):2495-507.
  19. Goldstein SL. (2012). Acute Kidney Injury in Children and Its Potential Consequences in Adulthood. Blood Purif. 33(1-3):131‐7.
  20. Siegler RL, Pavia AT, Cook JB. (1997). Hemolytic-uremic Syndrome in Adolescents. Arch Pediatr Adolesc Med. 151(2):165‐9.
  21. Siegler RL, et al. (1991). Long-term Outcome and Prognostic Indicators in the Hemolytic-Uremic Syndrome. J Pediatr. 118(2):195‐200.
  22. Tremblay JM, et al. (2013). A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2. Infect Immun. 81(12):4592-603.
  23. Agbas A, et al. (2018). Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab. Pediatr Nephrol. 33(12):2371-81.
  24. Weil BR, Andreoli SP, Billmire DF. (2010). Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome. Pediatr Nephrol. 25(9):1693-8.
  25. Andreoli SP, Bergstein JM. (1982). Development of insulin-dependent diabetes mellitus during the hemolytic-uremic syndrome. J Pediatr. 100(4):541-5.
  26. Burns JC, Berman ER, Fagre JL, Shikes RH, Lum GM. (1982). Pancreatic islet cell necrosis: association with hemolytic-uremic syndrome. J Pediatr. 100(4):582-4.
  27. Andreoli S, Bergstein J. (1987). Exocrine and endocrine pancreatic insufficiency and calcinosis after hemolytic uremic syndrome. J Pediatr. 110(5):816-7.
  28. Nesmith JD, Ellis E. (2007). Childhood hemolytic uremic syndrome is associated with adolescent-onset diabetes mellitus. Pediatr Nephrol. 22(2):294-7.
  29. Schlieper A, et al. (1999). Neuropsychological sequelae of haemolytic uraemic syndrome. Arch Dis Child. 80(3):214-20.
  30. Qamar IU, et al. (1996). Long-term neurological sequelae of hemolytic-uremic syndrome: a preliminary report. Pediatr Nephrol. 10(4):504-6.
  31. Bauer A, et al. (2014). Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome. Pediatr Nephrol. 29(9):1607-15.
  32. Oakes RS, Kirkham JK, Nelson RD, Siegler RL. (2008). Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol. 23(8):1303-8.
  33. Gagnadoux MF, et al. (1996). Long-term (15-25 Years) Outcome of Childhood Hemolytic-Uremic Syndrome. Clin Nephrol. 46(1):39-41.
  34. Calletti MG, Gallo G, Gianantonio CA. (1996). Development of Focal Segmental Sclerosis and Hyalinosis in Hemolytic Uremic Syndrome. Pediatr Nephrol. 10(6):687-92.
  35. Fitzpatrick R. (1991). Surveys of patients satisfaction: I-- Important general considerations. BMJ. 302(6781):887-9.
  36. Tonshoff B, et al. (1994). Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron. 68:63–70.
  37. Calderon-Margalit R. (2018). History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease. N Engl J Med. 378:428-38.
  38. Ingelfinger JR. (2018). A Disturbing Legacy of Childhood Kidney Disease. N Engl J Med. 378:470-1.
  39. Martin-Navarro JA, et al. (2013). Long-term renal prognosis of typical haemolytic-uremic syndrome suffered in infancy. Nefrologia. 33(3):433-5. 
  40. Vaterodt L, et al. (2018). Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood. Frontiers in Pediatrics. 6:220.
  41. Mammen C, et al. (2012). Long-term Risk of CKD in Children Surviving Episodes of Acute Kidney Injury in the Intensive Care Unit: A Prospective Cohort Study. Am J Kidney Dis. 59(4):523-30.
  42. Heung M, Chawla LS. (2012). Predicting Progression to Chronic Kidney Disease After Recovery From Acute Kidney Injury. Curr Opin Nephrol Hypertens. 21(6):628-34.
  43. Monet-Didailler C, et al. (2019). Long-term Outcome of Diarrhea-Associated Hemolytic Uremic Syndrome Is Poorly Related to Markers of Kidney Injury at 1-year Follow-Up in a Population-Based Cohort. Pediatr Nephrol. 34(4):657-62.
  44. Small G, Watson AR, Evans JH, Gallagher J. (1999). Hemolytic Uremic Syndrome: Defining the Need for Long-Term Follow-Up. Clin Nephrol. 52(6):352-6.

More Information

November 16, 2024

What are ways to prevent E. coli Outbreaks at catered events?

E. coli outbreaks can sometimes be linked to food served by caterers, and several factors can contribute to these incidents. Here are some of the risks and considerations associated with ...

November 08, 2024

Marler Clark calls on McDonalds to step up and pay customers Medical Bills and lost Wages

Bill Marler, food safety advocate and foodborne illness attorney since 1993, whose Seattle law firm, Marler Clark’s work was recently profiled in the Netflix documentary “Poisoned,” The Dirty Truth about ...

October 25, 2024

Marler Clark, the Food Safety Law Firm, weighs in with E. coli Lawsuit against McDonalds

Today the E. coli attorneys at Marler Clark filed a lawsuit against McDonald’s Corporation on behalf of Sarah Johnson, in the District Court of the District of Nebraska (Complaint # ...

October 01, 2024

How To Relieve E. coli Food Poisoning Symptoms

Dealing with an E. coli infection can be challenging due to the discomfort and potential severity of symptoms. Proper care and attention can help manage the symptoms and provide relief ...
  • View all

    • All Hemolytic Uremic Syndrome Resources

    Hemolytic Uremic Syndrome (HUS)
    Symptoms of HUS
    Treatment for HUS
    HUS Outcomes
    HUS and Kidney Transplantation
    HUS Research
    HUS References

    Other foodborne illnesses

    E. coli Salmonella Listeria Hepatitis A Reactive Arthritis Guillain-Barre Syndrome Irritable Bowel Syndrome Norovirus Botulism Campylobacter Shigella Cyclospora